Estimated Absorbed Dose After Intravenous Administration of 68Ga-BBN-RGD (mSv/MBq; n = 5; 4 Men and 1 Woman)
| Target organ | Mean | SD |
| Adrenals | 4.70E−03 | 1.45E−03 |
| Brain | 1.32E−03 | 1.80E–04 |
| Breasts | 2.50E–03 | 1.00E–03 |
| Gallbladder wall | 4.88E–03 | 1.25E–03 |
| Lower large intestine wall | 7.16E–03 | 1.71E–03 |
| Small intestine | 5.02E–03 | 1.38E–03 |
| Stomach wall | 3.95E–03 | 1.18E–03 |
| Upper large intestine wall | 4.70E–03 | 1.36E–03 |
| Heart wall | 8.38E–03 | 2.31E–03 |
| Kidneys | 6.47E–02 | 4.36E–02 |
| Liver | 1.55E–02 | 6.11E–03 |
| Lungs | 3.88E–03 | 8.39E–04 |
| Muscle | 4.48E–03 | 1.09E–03 |
| Ovaries | 6.97E–03 | 1.70E–03 |
| Pancreas | 5.23E–02 | 1.73E–02 |
| Red marrow | 4.89E–03 | 7.66E–04 |
| Osteogenic cells | 5.32E–03 | 1.58E–03 |
| Skin | 2.64E–03 | 9.64E–04 |
| Spleen | 1.14E–02 | 4.25E–03 |
| Testes | 4.85E–03 | 1.04E–03 |
| Thymus | 2.90E–03 | 1.01E–03 |
| Thyroid | 2.67E–03 | 9.75E–04 |
| Urinary bladder wall | 3.33E–01 | 1.60E–01 |
| Uterus | 1.55E–02 | |
| Total body | 5.43E–03 | 1.56E–03 |
| Effective dose equivalent | 3.21E–02 | 1.38E–02 |
| Effective dose | 2.23E–02 | 9.26E–03 |